These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2770489)

  • 1. [The drug treatment of gout].
    Ignat'ev MV
    Med Sestra; 1989 May; 48(5):48-51. PubMed ID: 2770489
    [No Abstract]   [Full Text] [Related]  

  • 2. Colchicine in acute gout.
    Morgan L
    Aust Fam Physician; 2008 Mar; 37(3):103; author reply 103. PubMed ID: 18376515
    [No Abstract]   [Full Text] [Related]  

  • 3. Febuxostat provides new gout treatment option.
    Belavic JM
    Nurse Pract; 2010 Mar; 35(3):9-10. PubMed ID: 20164728
    [No Abstract]   [Full Text] [Related]  

  • 4. Febuxostat (Uloric) for chronic treatment of gout.
    Med Lett Drugs Ther; 2009 May; 51(1312):37-8. PubMed ID: 19448587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is there still a place for colchicine in the treatment of acute gout?
    Grahame R
    Int J Clin Pract; 2007 Dec; 61(12):1966-7. PubMed ID: 17997801
    [No Abstract]   [Full Text] [Related]  

  • 6. Colchicine: time to rethink.
    Varughese GI; Varghese AI; Tahrani AA
    N Z Med J; 2007 Feb; 120(1249):U2429. PubMed ID: 17308565
    [No Abstract]   [Full Text] [Related]  

  • 7. Colchicine in acute gout: the need for a reappraisal.
    Varughese GI; Jammalamadaka D; Varghese AI; Babu S; Reddy M
    Int J Clin Pract; 2007 Dec; 61(12):2132-3. PubMed ID: 17997813
    [No Abstract]   [Full Text] [Related]  

  • 8. Febuxostat versus allopurinol for gout.
    Gelber AC
    N Engl J Med; 2006 Apr; 354(14):1532-3; author reply 1532-3. PubMed ID: 16602151
    [No Abstract]   [Full Text] [Related]  

  • 9. [Gout: diagnosis and therapy].
    Schlapbach P
    Ther Umsch; 1985 Oct; 42(10):687-90. PubMed ID: 3909489
    [No Abstract]   [Full Text] [Related]  

  • 10. Gout.
    Corkill MM
    N Z Med J; 1994 Aug; 107(984):337-9. PubMed ID: 8072733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 12. [Therapy of gout. Management of an acute attack--secondary prevention].
    Keitel R; Keitel W
    MMW Fortschr Med; 2000 Mar; 142(12):48-50. PubMed ID: 10804720
    [No Abstract]   [Full Text] [Related]  

  • 13. Management of gout.
    Sarkozi J
    N Engl J Med; 1996 Jun; 334(23):1543; author reply 1543-4. PubMed ID: 8618614
    [No Abstract]   [Full Text] [Related]  

  • 14. Colchicine: caution!
    Prescrire Int; 2011 Mar; 20(114):70. PubMed ID: 21649967
    [No Abstract]   [Full Text] [Related]  

  • 15. Colchicine--what is its place in the management of acute gout?
    Winzenberg T; Zochling J
    Aust Fam Physician; 2007 Jul; 36(7):529-30. PubMed ID: 17619668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Use of non-steroidal antirheumatic drugs in acute gout].
    Prillwitz H; Flatz A; von Elm E
    Praxis (Bern 1994); 2015 Aug; 104(16):865-6. PubMed ID: 26242422
    [No Abstract]   [Full Text] [Related]  

  • 17. [Current treatment of hyperuricemia and gout].
    Vukotić D
    Med Pregl; 1982; 35(5-6):213-7. PubMed ID: 7177063
    [No Abstract]   [Full Text] [Related]  

  • 18. Pegloticase, a polyethylene glycol conjugate of uricase for the potential intravenous treatment of gout.
    Biggers K; Scheinfeld N
    Curr Opin Investig Drugs; 2008 Apr; 9(4):422-9. PubMed ID: 18393109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic diseases: gout.
    Falasca GF
    Clin Dermatol; 2006; 24(6):498-508. PubMed ID: 17113968
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Febuxostat hypersensitivity.
    Abeles AM
    J Rheumatol; 2012 Mar; 39(3):659. PubMed ID: 22383358
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.